COVID-19 vaccines

2023 - 10 - 27

Pfizer and BioNTech Announce Positive Topline Data for mRNA ... (Pfizer)

In the clinical trial, the vaccine candidates were compared to a licensed influenza vaccine and the companies' Omicron BA.4/BA.5-adapted bivalent COVID-19 ...

Post cover
Image courtesy of "MedPage Today"

Tinnitus Worsens for Vaccine Scientist Who Points to Onset After ... (MedPage Today)

Gregory Poland, MD, said his tinnitus got worse after COVID infection.

Moderna Begins Phase 3 Trial for its Influenza-COVID-19 Vaccine (Contagionlive.com)

The company dosed its first study participant with its investigational vaccine, mRNA-1083. And this follows recent data reported from their phase 1/2 trial ...

Post cover
Image courtesy of "Contemporary Pediatrics"

Combination influenza and COVID-19 vaccine program ... (Contemporary Pediatrics)

The combination vaccine candidates demonstrated a safety profile consistent with Pfizer's COVID-19 vaccine. A phase 3 trial is anticipated to commence in ...

Post cover
Image courtesy of "Yale Insights"

The Latest on COVID-19 Vaccines, and Other News (Yale Insights)

Howie and Harlan discuss current issues in healthcare, including burnout at the hospital, the downsides to Medicare Advantage, and how AI is helping ...

Post cover
Image courtesy of "PrecisionVaccinations"

Influenza and mRNA COVID-19 Vaccine Combo Posts Positive ... (PrecisionVaccinations)

Pfizer Inc. and BioNTech SE today announced positive topline results from a Phase 1/2 clinical study evaluating the safety, tolerability, and immunogenicity ...

Post cover
Image courtesy of "Medscape"

mRNA Vaccine Cuts COVID-Related Guillain-Barrรฉ Risk (Medscape)

GBS cases (n = 76) were identified based on hospital discharge data from January 2021 to June 2022. For every GBS case, investigators chose 10 controls at ...

Post cover
Image courtesy of "WXYZ"

Pfizer's COVID, flu combination vaccine moving to final stage of trial (WXYZ)

Pfizer is moving ahead with the final-stage trial of its combination COVID-19 and flu vaccine candidates.

Post cover
Image courtesy of "The Hill"

Combined COVID-flu vaccine from Pfizer, BioNTech moving to late ... (The Hill)

Pfizer and BioNTech announced Thursday it would soon begin a Phase 3 trial for its combined flu and COVID-19 mRNA vaccine following โ€œpositiveโ€ results from ...

Explore the last week